Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Journal article

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT.

Journal article

Gathercole R. et al, (2021), Health Technol Assess, 25, 1 - 156

Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT

Journal article

Howard R. et al, (2020), Efficacy and Mechanism Evaluation, 7, 1 - 62

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.

Journal article

Howard R. et al, (2018), Health Technol Assess, 22, 1 - 62

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1353 - 1361

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1341 - 1352